Type : Contract
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40123P00366 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT 2024
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40123P00366 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT 2024
Active Pharmaceutical Ingredients (API) Manufacturer Data Acquisition - For full description of the reqirement, please review the attached RFQ document.
Food and Drug Administration’s (FDA), Center for Drug Evaluation and Research (CDER), requires a contract to obtain Active Pharmaceutical Ingredients’ (API), their manufacturing facilities and their activities.Please see enclosed RFP for full details.
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40122P00346 Ultimate Completion Date: Sun Sep 24 17:00:00 GMT 2023
Sources Sought Only - API Manufacturec Data AcquisitionSee attached document for full description of the requirement
Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), intends to purchase and store Active Pharmaceutical Ingredients (API’s). The Government intends to evaluate offers and award a contract without discussions with Offerors providing the requested services.Performance is anticipated to begin August 1, 2020.
ASPR IBMSC through the BARDA PCI BioMaP-Consortium is seeking to develop a biological design-build-test cycle at population scale, beginning with an analytical/paper demonstration of production of small molecule drug substances at commercial scale. This objective will support ASPR IBMSC’s broader long-term goal of developing and commercializing infrastructure that will be accessible to a broad community of users for the purpose of three biologically derived small molecule drug substances, creating a new manufacturing paradigm that can be competitive in the global market and to onshore drug production. The objective of this project is to demonstrate the ability to produce three (3) biologically derived small molecule drug substances at popul...